Vitamin D and Inflammatory Markers of Cardiovascular Disease in African Americans With Type 2 Diabetes
Status:
Unknown status
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
Recent clinical trials in non diabetics showed that vitamin D supplementation markedly
reduced serum levels of C-reactive protein (CRP), interleukin-6, and tissue matrix
metallo-proteinases. Our study objective is to evaluate if administration of vitamin D in
African Americans with hypovitaminosis D and DM Type 2 decreases serum levels of
inflammatory/thrombotic markers such as CRP: Highly Sensitive C Reactive Protein.